Lingzhi for Cancer Children

Launched by CHINESE UNIVERSITY OF HONG KONG · Dec 17, 2007

Keywords

ClinConnect Summary

Alternative and complementary medicine are widely used in treating children with cancers. A population-based survey in British Columbia revealed that they were used by 42% of the respondents. Among Chinese in Hong Kong, Traditional Chinese Medicine (TCM) is also widely practiced. Some 60% of the population had consulted TCM practitioners at one time or another. TCM use could be dated back to more than five thousand years ago, and written records were available for over two thousand years. TCM is considered to be an integral part of the Chinese culture. In our experience, TCM is believed to ...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Male and female patients aged 2-18 years
• • Acute lymphoblastic leukaemia who completed induction chemotherapy and pending maintenance chemotherapy treatment
• • Solid tumours completed chemotherapy
• • Aute myeloid leukaemia who completed induction and consolidation chemotherapy treatment
• • All patients and their parents signed informed written consent
• Exclusion Criteria:
• • Relapsed cancer patients
• • Received Traditional Chinese Medicine (TCM) treatment within preceding one month
• • Could not swallow capsules
• • Syndromal disorders (e.g. Down syndrome)
• • History of hypersensitivity reaction to Lingzhi or any TCM
• • Significant gastrointestinal, renal, hepatic, bronchopulmonary, neurological, cardiovascular or allergic diseases
• • In the judgement of investigators were unable to comply with study protocol requirements